| Class 2 Device Recall White Blood Cell (WBC) ReagentPart A used with the CELLDYN 4000 and CELLDYN Sapphire Systems | |
Date Initiated by Firm | December 19, 2007 |
Date Posted | May 14, 2008 |
Recall Status1 |
Terminated 3 on July 02, 2008 |
Recall Number | Z-1103-2008 |
Recall Event ID |
46296 |
510(K)Number | K051215 K961439 |
Product Classification |
Red cell lysing reagent - Product Code GGK
|
Product | White Blood Cell (WBC) Reagent-Part A used with the CELL-DYN 4000 and CELL-DYN Sapphire Systems, Red cell lysing reagent, List Number 01H77-01, Supplied in 3.8L bottles, Abbott Laboratories, Abbott Park, IL 60064 |
Code Information |
Lot Numbers: 51749i2, 51754i2 and 56675i2. |
Recalling Firm/ Manufacturer |
Abbott Laboratories 5440 Patrick Henry Dr Santa Clara CA 95054-1113
|
For Additional Information Contact | 408-982-4800 |
Manufacturer Reason for Recall | Microbial Contamination: The WBC (White Blood Cell) Reagent Part A was confirmed positive for Pseudomonas contamination. |
FDA Determined Cause 2 | Material/Component Contamination |
Action | Consignees were notified by a Product Recall letter sent 12/19/07. The letter instructs users to discontinue use of affected product and destroy any remaining inventory. Users were requested to return a customer reply form. For additional information, contact 1-877-4ABBOTT. |
Quantity in Commerce | Product was distributed in the follow amounts: 1,199 botttles of lot code 51749i2; 1,150 bottles of lot code 1574i2, 1,150 bottles of lot code 56675i2 |
Distribution | Worldwide Distribution including USA states of : AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WI and WV, and countries of: Argentina, Australia, Brazil, Canada, Germany, Hong Kong, Japan, Singapore, South Korea and Venezuela. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = GGK 510(K)s with Product Code = GGK
|
|
|
|